CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER

LOE Approaching

ceftriaxone

NDAINJECTIONINJECTABLE
Approved
Apr 2005
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
16

Mechanism of Action

12.1 Mechanism of Action Ceftriaxone is an antibacterial drug [see ]. 12.3 Pharmacokinetics Average plasma concentrations of ceftriaxone following a single 30-minute intravenous (IV) infusion of a 0.5, 1 or 2 g dose in healthy subjects are presented in Table 2. Multiple IV doses ranging from 0.5 to…

Clinical Trials (5)

NCT07207876N/ARecruiting

Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy

Started Feb 2026
NCT04010539Phase 3Completed

A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea

Started Oct 2019
628 enrolled
Gonorrhea
NCT01371838Phase 3Completed

A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia

Started Dec 2011
848 enrolled
Community-Acquired Bacterial PneumoniaLung Infection of Individual Not Recently Hospitalized
NCT01602874Phase 3Withdrawn

Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia

Started Jan 2011
0
Community Acquired Bacterial PneumoniaComplicated Intra-Abdominal Infection
NCT00895089Phase 4Completed

Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver Abscess

Started May 2009
24 enrolled
Liver Abscess